Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem von Larsen, P.J, Tang-Christensen, M, Holst, J.J, Ørskov, C

Volltext

Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice von Thulesen, J, Hartmann, B, Hare, K J, Kissow, H, Ørskov, C, Holst, J J, Poulsen, S S

Volltext

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients von NAUCK, M. A, KLEINE, N, ØRSKOV, C, HOLST, J. J, WILLS, B, CREUTZFELDT, W

Volltext

Glucagon-like peptide-1, a new hormone of the entero-insular axis von ØRSKOV, C

Volltext

Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM von NAUCK, M. A, WOLLSCHLÄGER, D, WERNER, J, HOLST, J. J, ØRSKOV, C, CREUTZFELDT, W, WILLMS, B

Volltext

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus von NAUCK, M. A, HEIMESAAT, M. M, ØRSKOV, C, HOLST, J. J, EBERT, R, CREUTZFELDT, W

Volltext

The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas von DE HEER, J, PEDERSEN, J, ORSKOV, C, HOLST, J. J

Volltext

IFNγ and Perforin Cooperate to Control Infection and Prevent Fatal Pathology During Persistent Gammaherpesvirus Infection in Mice von Bartholdy, C., Høgh‐Petersen, M., Storm, P., Holst, P. J., Ørskov, C., Christensen, J. P., Thomsen, A. R.

Volltext

GLP-1 does not acutely affect insulin sensitivity in healthy man von ØRSKOV, L, HOLST, J. J, MØLLER, J, ØRSKOV, C, MØLLER, N, ALBERTI, K. G. M. M, SCHMITZ, O

Volltext

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine von ØRSKOV, C, JEPPESEN, J, MADSBAD, S, HOLST, J. J

Volltext

Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus von Gutniak, Mark, Ørkov, Cathrine, Holst, Jens J, Ahrén, Bo, Efendić, Suad

Volltext

Targets and tactics: the relative importance of HbA1c, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes von Woo, V., Shestakova, M. V., Ørskov, C., Ceriello, A.

Volltext

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut von Holst, J.J., Ørskov, C., Vagn Nielsen, O., Schwartz, T.W.

Volltext

Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in Type 2 diabetic patients von Nauck, M.A., Weber, I., Bach, I., Richter, S., Ørskov, C., Holst, J.J., Schmiegel, W.

Volltext

Good glycaemic control: an international perspective on bridging the gap between theory and practice in type 2 diabetes von Kilpatrick, E. S., Das, A. K., Ørskov, C., Berntorp, K.

Volltext

Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man von Hvidberg, Annemarie, Nielsen, Maibritt Toft, Hilsted, Jannik, Ørskov, Cathrine, Holst, Jens Juul

Volltext

Nitric Oxide Has Tonic Inhibitory Effect, But Is Not Involved in the Vagal Control or VIP Effects on Motility of the Porcine Antrum von SCHMIDT, P. T, ØRSKOV, C, RASMUSSEN, T. N, HOLST, J. J

Volltext

Glucagon-like Peptide 1 (7-36 hide) Secretion in Response to Luminal Sucrose from the Upper and Lower Gut: A Study Using α-Glucosidase Inhibition (Acarbose) von Qualmann, C., Nauck, M. A., Holst, J. J., øSrskov, C., Creutzfeldt, W.

Volltext

Pancreatic and intestinal processing of proglucagon in man von ØRSKOV, C, HOLST, J. J, POULSEN, S. S, KIRKEGAARD, P

Volltext

Glucagon-Like Peptide-1 7-36 Amide and Peptide YY from the L-Cell of the Ileal Mucosa Are Potent Inhibitors of Vagally Induced Gastric Acid Secretion in Man von Wettergren, A., Petersen, H., ørskov, C., Christiansen, J., Sheikh, S. P., Holst, J. J.

Volltext